Danone plans to double India sales in 3 years
Nov 29 2012 , Mumbai
Danone early this year paid about $355 million to buy Indian drugmaker Wockhardt's nutrition business that sells popular brands such as Dexolac, Farex and Nusobee. The brands compete with Danone's top global rival Nestle.
"India's growth in nutrition sector will outpace China's (growth)," Laurent Marcel, managing director at Danone's India nutrition business unit, told reporters on Thursday. "We are here to expand, grow the business."
India's baby nutrition market is valued about 25 billion rupees, in which Danone holds about 8 percent share, he said.